Vectron's CSO, Jostein Malmo, co-authored a recent article published in Frontiers in Chemical Engineering this week.  The article gives valuable and detailed insights into the metabolic burden that recombinant protein production can cause to the cells and the critical impact of induction for strong promoters.  Vectron, a portfolio company of Dynamk Capital, has become the premier microbial protein production experts, developing solutions for protein expression systems are core to their service.